ABSTRACT. Genetic heterogeneity in 12 patients from 11 different families with X-linked recessive chronic granulomatous disease was studied by Southern blot analysis using cytochrome b heavy-chain cDNA as a probe. We found the abnormal restriction length fragment patterns of the cytochrome b heavy-chain gene in three families, which were not observed in healthy controls. DNA from one patient showed the abnormal patterns after digestion with several restriction enzymes. The DNA of two other patients showed the abnormality only with TaqI and PstI. Analysis of the same family members indicated that these abnormal patterns cosegregated with the disease. The other nine patients from eight families did not have any abnormalities detectable by Southern blot analysis. Although further experimentation should be done to study the molecular genetic heterogeneity in most X-linked chronic granulomatous disease families (eight of 11), we were able to demonstrate at least three different types of mutations in the cytochrome b heavy-chain gene responsible for the disease.
number of families (5, 1 1-13). In this study, we found three novel mutations in three independent families with X-linked CGD detected by Southern blot analysis.
MATERIALS AND METHODS
Patients. We studied 12 patients from 1 1 different families (two of whom had the same maternal grandmother) with Xlinked CGD. Patients were all male and ranged from 1 to 15 y of age (Table I) . One patient died before the study was undertaken; his frozen leukocyte pellet was used for the analysis. Diagnosis of CGD was based on family and personal history of recurrent pyogenic infections, on the findings of defective reduction of nitroblue tetrazolium and impaired chemiluminescence production by neutrophils. Twelve CGD patients were considered to have X-linked inheritance, according to their family histories and familial granulocyte functions, studied by the tests mentioned above. All mothers of the patients were supposed to be camers for the disease from the results of subnormal reduction of nitroblue tetrazolium. DNA samples from available family members and healthy controls were also used for the analysis.
Western blot analysis. Detection of cytochrome b heavy-and light-chain protein of neutrophils was performed as described (14) . Antibodies used for heavy and light chains were anti& (against amino acid residues 150-172 of heavy-chain residues) and anti& (against amino acid residues 175-194 of light-chain residues), respectively ( 14) .
Preparation of genomic DNA and Sourhern blot analysis. High molecular weight DNA was extracted from peripheral blood leukocytes, or from established Epstein-Ban virus-transformed B cell lines using standard methods described elsewhere (15) . DNA was quantified by absorbance at 260 nm, and 7.5 pg of DNA was digested with restriction enzymes (BamHI, BglII, EcoRI, HindIII, PstI, PvuII, SacI, and TaqI) (Takara Shuzo Co., Ltd., Kyoto, Japan). DNA samples were separated by electrophoresis on 0.8% agarose gels and blotted onto nitrocellulose (Schleicher & Schuell Inc., Keene, NH) after treatment according to Wahl et al. (16) . Prehybridization and hybridization were carried out at 42°C in a mixture containing 50% formamide. The cytochrome b heavy-chain cDNA, approximately 1.8 kb (encompassing the entire coding region) cloned into the HindIII site in the psV vector, was kindly provided by Dr. Stuart H.
Orkin (Haward Medical School, Boston, MA). The full-length cDNA (1.8 kb) used as a probe was purified from the gel, after the vector including the cDNA had been digested with HindIII, and was separated by electrophoresis. A 5' fragment (0.2 kb; HindIIIIPsrI), and a 3' fragment (0.3 kb; HindIIIIEcoRI of the full-length cDNA were also purified from the gel and used as probes. Labeling of the probes was achieved by oligolabeling methods (17) (Takara Shuzo Co., Ltd.) using (U-(~*P]~CTP (Amersham Corp., Arlington, IL). After washing the filter, hybridization patterns were visualized by autoradiography. (Table 1 ). The analysis for patient 10 could not be performed because he died before the study was undertaken.
The abnormal restriction fragment patterns of the cytochrome b heavy-chain gene were detected in three patients with X-linked CGD (CGD 1, CGD4, and CGD5). The other nine patients (eight different families) did not show any abnormalities detectable by Southern blot analysis. DNA from CGD patient 1 showed absence of one band (1.8 kb) after Tag1 digestion and hybridization with cytochrome b heavy-chain cDNA (Fig. 1, lane 1) . DNA samples from more t Died before this study.
$ Not studied.
( bands, all of which were observed in controls, were missing. DNA from his mother (Fig.  3 , lane 2) and his maternal grandmother (Fig. 3, lane 3) showed the same abnormal bands mentioned above, together with bands that were observed in controls but not detected in the patient (Fig. 3, lane 4) . His sister's DNA did not show the abnormal bands on Southern blot analysis (Fig. 3) . To begin to localize the mutation responsible for the abnormal bands on the Southern blot analysis, the 5' fragment (0.2 kb) or the 3' fragment (0.3 kb) of the 1.8-kb cytochrome b heavy-chain cDNA was used for hybridization. The abnormality was revealed again with the 3' probe of the cytochrome b heavy-chain cDNA, after digestion with HindIII, PvuII (Fig. 4C) , and Sad. No abnormal band was detected with the 5' probe (Fig. 4B) . DNA from CGD patient 5 revealed the abnormal pattern with PstI using the full-length cytochrome b heavy-chain cDNA probe. Two bands, approximately 11 and 2.0 kb, were missing, and a 13-kb band, which was not detected in DNA from healthy controls, was observed on Southern blot analysis (Fig. 5, lane I) . His mother's DNA was revealed to have the 11-and the 2.0-kb bands, together with the 13-kb band, when it was digested with PstI and hybridized with the full-length probe (Fig. 5, lane 2) . No abnormal band was detected with any of the other restriction endonucleases that we used. bands, and large arrows indicated abnormal bands.
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ARIGA E T AL. (indicated by a large arrow). His mother's DNA had all of the bands described above.
DISCUSSION
We have demonstrated the molecular genetic heterogeneity detectable on Southern blot analysis in three families with Xlinked CGD. The abnormal patterns of the cytochrome b heavychain gene observed in the three CGD patients differed from each other. Southern blots of DNA from family members of the patients indicated that the abnormal patterns cosegregated with the disease. As reported recently (18), no restriction fragment length polymorphism was observed in healthy individuals with any of the restriction enzymes that we used in the study. It, therefore, seemed likely that the abnormal patterns on the Southern blot observed in patients were the results of mutations in the cytochrome b heavy-chain gene responsible for the disease.
The DNA of CGD patient 4 showed the abnormal patterns of the cytochrome b heavy-chain gene after digestion with several restriction enzymes and hybridized with the full-length cytochrome b heavy-chain cDNA. His mother and maternal grandmother, who are presumed to be camers of the disease, also had the same mutant gene (Fig. 3, lane 2 and 3) . Furthermore, we were able to determine that his sister was not a camer of the disease (Fig. 3, lane 4) , because she did not have the same allele of the cytochrome b heavy-chain gene that the patient possessed. Because the abnormal band was observed again using not the 5' fragment, but rather the 3' fragment of cytochrome b cDNA on Southern blot analysis, the mutation responsible for the disease in the CGD patient 4 seemed to be located near, but not in, the portion corresponding to the 3' fragment of cDNA. This mutation looked different from a partial deletion in the cytochrome b heavy-chain gene, which has previously been reported (5, 13).
Further molecular study will be necessary to characterize the mutation in CGD patient 4.
The mutation in CGD patient 1 seemed not to be a grossly detectable gene deletion or rearrangement of the cytochrome b heavy-chain gene, because the abnormal band of the gene was observed only after digestion with TaqI. No abnormality was
detected with any other endonuclease that we used. Because the TaqI recognition site "TCGA" includes dinucleotide "CpG," which is the hot spot for the point mutation (1 9), the mutation in CGD patient 1 might be located at one of four TaqI sites in the exon in the cytochrome b heavy-chain gene (5) . The absence of the 1.8-kb band in this patient was more likely due to a change in size and overlapping of one of the bands observed on the film. The possibility of a partial deletion in the gene was small, because we could not detect the abnormality of the gene with any other restriction enzymes. DNA samples from more than 20 normal controls and the healthy brother of CGD patient 1 (Fig. 1, lane  4) did not have the same pattern as the patient with this enzyme. This was consistent with the hypothesis that this pattern cosegregated with the disease and was the result of the mutation responsible for the disease. However, we cannot exclude the possibility that this abnormality on the Southern blot was linked to the disease but was not due to the mutation responsible for the disease.
Although CGD patient 5 was shown to have both cytochrome b chains on Western blot studies [we also revealed that both of the cytosolic factors (47 and 65 kD) of the patient's granulocytes were positive on Western blot analysis (not shown)], we think that the mutation responsible for the disease in the patient is in the cytochrome b heavy-chain gene because we detected the abnormal restriction length pattern of the gene, which was not seen in normal individuals. The mutation of the patient that seemed to result in dysfunctional cytochrome b protein also seemed not to have a gross abnormality in the cytochrome b heavy-chain gene structure. The mutation of the gene was detected only after digestion with PstI, and control DNA samples did not show any polymorphic pattern of the gene with this enzyme. Furthermore, Southern blot study of the DNA of the patient's mother indicated that this PstI abnormality cosegregated with the disease. Because she was a carrier of the disease, she had the same mutation in the cytochrome b heavy-chain gene together with the normal gene. This PstI abnormality would be very helpful to determine carrier state of the disease in this family. Further study to characterize the mutation in this patient would be very helpful to understand the functional domain of cytochrome b heavy chain, and it is presently underway.
The other nine patients from eight families did not reveal any abnormal pattern of the cytochrome b heavy-chain gene on Southern blot analysis with any of the enzymes that we used. This suggests that these mutations also involve a small portion of the gene. Thus, 10 of 1 1 families with X-linked CGD in this study appeared not to have a grossly detectable genetic mutation. This rate is consistent with a previous report that the abnormality of the cytochrome b heavy-chain gene on Southern blot study, which resulted from mutations, was observed in only one of 18 different families with X-linked CGD (5) . Further analysis should be done for the other eight families to define whether they have the same mutation or their mutations are heterogeneous.
